net net see mdlz sale ep guidanc achiev north
america remain thorn given snack categori emerg market growth
acceler sequenti yoy yoy respect
understand could find mdlz yoy organ sale outlook
conserv said view fact mdlz north america segment
remain stubbornli weak part due malwar issu like remain
investor concern mention potenti dampen top-lin
believ mdlz market share neutral plan may strike
aggress addit price expect hyperinflationari market
well like on-going pressur north america see top-lin plan base
neutral market share trend potenti overli optimist token
exclud malwar impact recogn market share roughli flat
yoy perhap support sanguin outlook
meanwhil see balanc contribut gross margin
sg leverag vs year past flattish yoy commod cost
favor fx impact expect greatest driver margin
improv improv volum trend also allow better flow
recent suppli chain improv mind view mdlz
oper margin target vs previou target rang like conserv
view increasingli like choos exit dsd
manag still believ north american dsd system power asset find
like ultim follow ks lead exit system fair
north america biscuit weak still relat malwar complet
dismantl dsd howev simpli believ much greater
competit advantag expect compani seen date
exit dsd see sort second mover advantag mention
potenti margin flexibl beyond howev could well come
neg price retail need greater compens work
quarterli annual ep usd
consensu number thomson reuter
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
link barclay live interact chart
overweight continu recommend
share given long-term potenti compani
deliv peer-lead sale earn growth
compani strateg option rel
valuat believ upsid
assum robust top-lin earn growth
along benefit fx see upsid
ep potenti appli price-to-earnings
multipl impli upsid valu
assum challeng organ sale backdrop
less favor fx less meaning margin
expans see potenti downsid
ep estim appli price-to-earnings
multipl impli downsid valu
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
street estim could rise account lower forecast interest expens
greater fx boost rais ep estim nearli lower
forecast interest expens add per share greater fx boost could add
ep vs previou estim share trade roughli price-to-earnings
multipl revis ep estim vs previous modest discount
peer think set reason floor rais price target
vs previous ep estim premium
group -- see warrant base higher ep estim slowli
andrew lazar herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
author contribut research report research analyst unless otherwis indic
public date top report reflect local time report produc may differ releas date provid
gmt
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis barclay research depart
oper independ absa research depart absa research produc absa bank limit act corpor
invest bank divis part barclay africa group limit affili invest bank barclay bank plc elig
client may receiv research report research depart may reach differ conclus may contain differ
conflict forecast recommend trade idea
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
